Reissue & Reexam Live Blog: Litigation Strategies

Next up is Scott McKeown of Oblon Spivak, writer for Patents Post Grant and Practice Center Contributor.  He discussed patent reexamination as a litigation tool.  Some highlights from his presentation…

  1. Reexamination v. Litigation Standards: A huge benefit of reexamination with concurrent litigation is in the lower standards. No presumption of validity, preponderance of evidence standard and broadest reasonable claim interpretation.
  2. Patents that are ideal for reexamination (invalidity purposes): broad claims, patents subject to inter partes reexam, predictable arts (KSR), and patents with alternative basis for attack.
  3. Patents that are less ideal (invalidity purposes only): famous products (TiVo, Plavix, iPhone), unpredictable arts (Chem, Bio/Pharma), large portfolios (Rambus), portfolios with active continuations.  However complete invalidity is only ONE of MANY litigation purposes. (more…)

02.4.11 | Patent Law Institute, Reexamination | Stefanie Levine